Literature DB >> 33600886

Longitudinal tracing of neurochemical metabolic disorders in working memory neural circuit and optogenetics modulation in rats with vascular cognitive impairment.

Huawei Lin1, Tingting Jin2, Lewen Chen1, Yaling Dai1, Weiwei Jia1, Xiaojun He1, Minguang Yang2, Jianhong Li2, Shengxiang Liang3, Jinsong Wu1, Jia Huang1, Lidian Chen2, Weilin Liu4, Jing Tao5.   

Abstract

Chronic cerebral ischemia leads to vascular cognitive impairment (VCI) that exacerbates along with ischemia time and eventually develops into dementia. Recent advances in molecular neuroimaging contribute to understand its pathological characteristics. We previously traced the anisotropic diffusion of water molecules suggests that chronic cerebral ischemia leads to irreversible progressive damage to white matter integrity. However, the abnormalities of gray matter activity following chronic cerebral ischemia remains not entirely understood. In this study, in vivo hydrogen proton magnetic resonance spectroscopy (1H-MRS) was applied to longitudinally track the neurochemical metabolic disorder of gray matter associated with working memory, and optogenetics modulation of neurochemical metabolism was performed for targeted treatment of VCI. The results showed that the concentration of N-acetylaspartate (NAA) in the right hippocampus, left hippocampus, right medial prefrontal cortex (mPFC) and mediodorsal thalamus was decreased as early as 7 days after chronic cerebral ischemia, subsequently gamma-aminobutyric acid (GABA) declined whereas myo-inositol (mI) and glutamate (Glu) increased at 14 days, as well as choline (Cho) lost at 28 days, concurrently the change of Glu and GABA in the mPFC and hippocampus was ischemia time-dependent manner within 1 month. Behaviorally, working memory and object recognition memory were impaired at 14 days, 28 days that significantly correlated with neurochemical metabolic disorders. Interestingly, using optogenetics modulation of PV neurons in the mPFC, the metabolic abnormalities of NAA and GABA in working memory neural circuit could be repaired after chronic cerebral ischemia, together with behavior improvements. These findings suggested that as early as 1∼4 weeks after chronic cerebral ischemia, the metabolism of NAA, Glu, mI and Cho was synchronously impaired in neural circuit of hippocampus-mediodorsal thalamus-mPFC, and the loss of GABA delayed in the hippocampus, and optogenetics modulation of parvalbumin (PV) neurons in the mPFC can improve the neurochemical metabolism of working memory neural circuit and enhance working memory.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic cerebral ischemia; Magnetic resonance spectroscopy; Neural circuit; Neurochemical metabolism; Vascular cognitive impairment; Working memory

Mesh:

Substances:

Year:  2021        PMID: 33600886     DOI: 10.1016/j.brainresbull.2021.02.013

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  Effect and Mechanism of Yisui Fuyongtang (YSFYT) Decoction on Cognitive Function and Synaptic Plasticity in Rats with Vascular Cognitive Impairment.

Authors:  Tingliang Gong; Zhaoliang Luo; Li Huang; Caixian Xiao; Junlu Yi; Junfeng Yan; Qian Chen; Weihong Li; Wenqiang Tao
Journal:  J Immunol Res       Date:  2022-07-08       Impact factor: 4.493

2.  Erythrocytes Are an Independent Protective Factor for Vascular Cognitive Impairment in Patients With Severe White Matter Hyperintensities.

Authors:  Xi Tao; Hang Zhou; Danheng Mo; Wenjie Zhang; Zihan Chang; Yiheng Zeng; Yuqi Luo; Siyuan Wu; Wenjing Tang; Chen Yang; Qing Wang
Journal:  Front Aging Neurosci       Date:  2022-02-18       Impact factor: 5.750

3.  Research hotspots and trends of multimodality MRI on vascular cognitive impairment in recent 12 years: A bibliometric analysis.

Authors:  Mei-Hui Xia; Ang Li; Rui-Xue Gao; Xiao-Ling Li; Qinhong Zhang; Xin Tong; Wei-Wei Zhao; Dan-Na Cao; Ze-Yi Wei; Jinhuan Yue
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.